Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag2S and PLGA@Ag2S@SPION Nanocarriers with Drug Release Capability

dc.centroFacultad de Cienciases_ES
dc.contributor.authorAlvear-Jiménez, Alexis
dc.contributor.authorZabala-Gutiérrez, Irene
dc.contributor.authorShen, Yingli
dc.contributor.authorVillaverde, Gonzalo
dc.contributor.authorLozano-Chamizo, Laura
dc.contributor.authorGuardia, Pablo
dc.contributor.authorTinoco, Miguel
dc.contributor.authorGacía-Pinel, Beatriz
dc.contributor.authorPrados, José
dc.contributor.authorMelguizo, Consolación
dc.contributor.authorLópez-Romero, Juan Manuel
dc.contributor.authorJaque, Daniel
dc.contributor.authorFilice, Marco
dc.contributor.authorContreras-Cáceres, Rafael
dc.date.accessioned2025-10-24T11:57:10Z
dc.date.available2025-10-24T11:57:10Z
dc.date.issued2022
dc.departamentoQuímica Orgánicaes_ES
dc.description.abstractAg2S nanoparticles are near-infrared (NIR) probes providing emission in a specific spectral range (~1200 nm), and superparamagnetic iron oxide nanoparticles (SPION) are colloidal systems able to respond to an external magnetic field. A disadvantage of Ag2S NPs is the attenuated luminescent properties are reduced in aqueous media and human fluids. Concerning SPION, the main drawback is the generation of undesirable clusters that reduce particle stability. Here, we fabricate biocompatible hybrid nanosystems combining Ag2S NPs and SPION by the electrospraying technique for drug delivery purposes. These nanostructures are composed of poly(lactic-co-glycolic acid) (PLGA) as the polymeric matrix in connection with both Ag2S NPs and SPIONs. Initially, we fabricate a hybrid colloidal nanosystem composed of Ag2S NPs in connection with PLGA (PLGA@Ag2S) by three different routes, showing good photoluminescent (PL) properties with relatively high average decay times. Then, we incorporate SPIONs, obtaining a PLGA polymeric matrix containing both Ag2S NPs and SPION (PLGA@Ag2S@SPION). Interestingly, in this hybrid system, the location of Ag2S NPs and SPIONs depends on the synthesis route performed during electrospraying. After a detailed characterization, we demonstrate the encapsulation and release capabilities, obtaining the kinetic release using a model chemotherapeutic drug (maslinic acid). Finally, we perform in vitro cytotoxicity assays using drug-loaded hybrid systems against several tumor cell lines.es_ES
dc.identifier.citationAlvear-Jiménez, A.; Zabala Gutierrez, I.; Shen, Y.; Villaverde, G.; Lozano-Chamizo, L.; Guardia, P.; Tinoco, M.; Garcia-Pinel, B.; Prados, J.; Melguizo, C.; et al. Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag2S and PLGA@Ag2S@SPION Nanocarriers with Drug Release Capability. Pharmaceutics 2022, 14, 214. https://doi.org/10.3390/pharmaceutics14010214es_ES
dc.identifier.doi10.3390/pharmaceutics14010214
dc.identifier.urihttps://hdl.handle.net/10630/40455
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rights.accessRightsopen accesses_ES
dc.subjectNanopartículases_ES
dc.subjectOxidos de hierroes_ES
dc.subjectBiocompatibilidades_ES
dc.subject.otherElectrosprayinges_ES
dc.subject.otherAg2S nanoparticleses_ES
dc.subject.otherSPIONses_ES
dc.subject.otherHybrid systemes_ES
dc.subject.otherChemotherapeutic druges_ES
dc.subject.otherDrug releasees_ES
dc.titleElectrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag2S and PLGA@Ag2S@SPION Nanocarriers with Drug Release Capabilityes_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationdaaaa2dc-4012-4ad3-9fee-4a0da3e1181a
relation.isAuthorOfPublication.latestForDiscoverydaaaa2dc-4012-4ad3-9fee-4a0da3e1181a

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022 Pharmaceutics 2022, 14, 214 DEF.pdf
Size:
6.28 MB
Format:
Adobe Portable Document Format
Description:

Collections